Table 2.
Age-adjusted reduction in breast cancer mortality rates (per 100000 women) in 2000 attributed to adjuvant treatment and/or screening relative to no screening and no adjuvant treatment for women aged 30 to 79 years*
| Model | All breast cancer cases | ER+ breast cancer cases | ER- breast cancer cases | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tam | Chemo | TX | SCR | SCR+TX | Tam | Chemo | TX | SCR | SCR+TX | Tam | Chemo | TX | SCR | SCR+ TX |
|
| D | 6 | 5 | 11 | 9 | 19 | 6 | 2 | 8 | 7 | 15 | 0 | 3 | 3 | 2 | 5 |
| E | 9 | 8 | 16 | 9 | 22 | 9 | 4 | 12 | 7 | 16 | 0 | 4 | 4 | 3 | 6 |
| G-E | 8 | 5 | 13 | 14 | 24 | 8 | 3 | 10 | 10 | 18 | 0 | 3 | 3 | 4 | 6 |
| M | 8 | 4 | 12 | 8 | 15 | 8 | 2 | 10 | 6 | 13 | 0 | 2 | 2 | 2 | 3 |
| S | 13 | 6 | 16 | 14 | 26 | 13 | 3 | 15 | 11 | 21 | 0 | 2 | 2 | 3 | 5 |
| W | 10 | 6 | 16 | 10 | 24 | 10 | 3 | 12 | 7 | 18 | 0 | 4 | 4 | 3 | 6 |
| Median | 8 | 6 | 14 | 10 | 23 | 8 | 3 | 11 | 7 | 17 | 0 | 3 | 3 | 3 | 5 |
* Mortality reductions are absolute reductions, computed as the difference between the rate predicted in the absence of both screening and adjuvant treatment and the rate predicted with one or both interventions. Chemo = chemotherapy; ER = estrogen receptor; SCR = screening mammography; SCR+TX = screening mammography and tamoxifen and chemotherapy; Tam = tamoxifen; TX = tamoxifen and chemotherapy.